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ABSTRACT 
 
Background: Adverse effects of maternal substance use during pregnancy on fetal 
development may increase risk of psychopathology. 
Aims: To examine whether maternal use of tobacco, cannabis or alcohol during 
pregnancy increases risk of offspring psychosis-like symptoms (PLIKS). 
Method: A longitudinal study of 6,356 adolescents, age 12, who completed a semi-
structured interview for psychotic symptoms in the ALSPAC birth cohort. 
Results: Frequency of maternal tobacco use during pregnancy was associated with 
increased risk of suspected or definite psychotic symptoms (adjusted OR = 1.20, 
95%CI 1.05, 1.37; p = 0.007). Maternal alcohol use showed a non-linear association 
with PLIKS, with this effect almost exclusively in the offspring of women drinking 
>21 units weekly. Maternal cannabis use was not associated with PLIKS. Results for 
paternal smoking during pregnancy and maternal smoking post-pregnancy lend some 
support for a causal effect of tobacco exposure in-utero on development of psychotic 
symptoms. 
Conclusions: These findings indicate that risk factors for development of non-clinical 
psychotic experiences may operate during early development. Future studies of how 
in-utero exposure to tobacco affects cerebral development and function may lead to 
increased understanding of the pathogenesis of psychotic phenomena. 
 
 
 
Declaration of interest: None of the authors have any conflicts of interest in relation 
to this work. 
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INTRODUCTION 
 
In the UK 15-20% of women continue to smoke throughout their pregnancy 
1
, and 
although cannabis use is much less common, some alcohol intake during pregnancy is 
reported by most women 
2
. Maternal substance use during pregnancy poses a potential 
risk to the health of the developing foetus as tobacco, alcohol and cannabis all cross 
the placenta and the foetal blood-brain brain barrier. It has become increasingly clear 
within the field of teratology that exogenous agents that are relatively harmless to the 
mother during pregnancy may have detrimental neurological effects on the child, and 
that most such effects are subtle and may not be detectable at birth 
3,4
.  
 
There is robust evidence from epidemiological and animal model studies that maternal 
tobacco use during pregnancy leads to a number of adverse perinatal outcomes 
5-7
. 
Maternal smoking has also been repeatedly reported as being associated with adverse 
long-term effects on the offspring, including reduced cognitive ability 
7-9
 and 
increased incidence of attention deficit hyperactivity disorder and conduct disorder 
during childhood and adolescence 
6,7,10-12
, with similar, though less consistent, reports 
for maternal cannabis and alcohol use 
4,8
. 
 
It is difficult to be confident that any associations between maternal substance use and 
child psychopathology from epidemiological studies are causal and not confounded 
by other characteristics of women who continue to use substances during pregnancy. 
In the absence of randomised trials, methods that would increase confidence that such 
associations are causal include examining whether associations observed are specific 
4 
to maternal (but not paternal) substance use during pregnancy 
13
.  However, very few 
studies of childhood psychopathology have utilized such approaches to date. 
 
Animal models that can support or refute causal mechanisms are more difficult to 
study for psychopathology than models of perinatal morbidity such as birthweight. 
Nevertheless, animal studies show that exposure to nicotine in-utero 
14,15
, and to a 
lesser extent exposure to alcohol and cannabinoids 
4,16
, can lead to profound and 
lasting changes in cerebral development and neurotransmitter function, making 
maternal substance use in pregnancy a very plausible risk factor for offspring 
psychopathology. 
 
Although there have been fewer studies that have examined the relationship between 
maternal substance use and other, non-externalising, forms of psychopathology, 
effects on depression or psychosis are equally plausible given the diverse detrimental 
effects of in-utero exposure to tobacco, cannabis or alcohol on cerebral development 
and function, and also given the evidence that such exposure can lead to cognitive 
deficits that are an established risk factor for psychosis (ref). Given that a wide range 
of obstetric and pregnancy complications have been associated with risk of 
schizophrenia in the offspring 
17
, it is perhaps surprising that there are so few studies 
that have focused on the effects of maternal substance use on risk of psychosis. One 
reason for this is that maternal smoking during pregnancy is often adjusted for as a 
possible confounder when examining obstetric complications, even though it is likely 
to be a valid marker of exposure to an adverse in-utero environment in its own right. 
In the systematic review by Cannon et al for example, there were only two studies 
identified for inclusion in the meta-analysis on maternal smoking 
18,19
. Although there 
5 
was no evidence of association between maternal smoking and schizophrenia in that 
meta-analysis 
17
, the numbers of subjects with schizophrenia in those studies means 
the statistical power to detect an association with maternal smoking is likely to have 
been relatively low. More recently, maternal smoking in pregnancy was associated 
with the presence of psychotic symptoms in the Early Developmental Stages of 
Psychopathology (EDSP) study of almost 1000 young adults in Munich 
20
. However 
as this was a cross-sectional design with retrospective recall of maternal behaviour 
during pregnancy, recall bias is difficult to exclude. 
 
Our aim in this study was to investigate, in a longitudinal design, whether maternal 
tobacco, cannabis or alcohol use during pregnancy were independently associated 
with risk of the offspring developing psychotic symptoms during early adolescence. 
We hypothesised that maternal tobacco, and to a lesser extent cannabis and alcohol 
use, would be associated with psychotic symptoms, and that a substantial part of this 
association would be mediated through effects of maternal substance use on adverse 
perinatal outcomes and cognitive ability during childhood. 
 
 
6 
METHOD 
 
Sample 
This study examines data from 6356 children from the Avon Longitudinal Study of 
Parents and Children (ALSPAC) cohort who participated in the Psychosis-Like 
Symptoms (PLIKS) semi-structured interview (PLIKSi) 
21
 when they were 12 years of 
age (data restricted to 1 child per nuclear family). The initial cohort consisted of 
14,062 children born to residents of the former Avon Health Authority area who had 
an expected date of delivery between 1
st
 April 1991 and 31st December 1992 
(www.alspac.bris.ac.uk). The cohort was set up to examine genetic and environmental 
determinants of health (including mental health) and development 
22
. The parents 
have completed regular postal questionnaires concerning their child’s health and 
development since birth. The children, since 7.5 years of age, have attended annual 
assessment clinics where they participate in a range of face-to-face interviews. Due to 
wave non-response, sample sizes in the analyses differ according to exposures and 
datasets examined (see Results & Tables). PLIKSi non-attendees were more likely to 
come from lower social class families, to have parents with lower education, to be 
male, and to be of minority ethnic status 
21
. 
 
Measures 
Outcomes: The PLIKSi consists of 12 core questions covering hallucinations (visual 
and auditory); delusions (delusions of being spied on, persecution, thoughts being 
read, reference, control, grandiose ability and other unspecified delusions); and 
experiences of thought interference (thought broadcasting, insertion and withdrawal) 
over the past 6-months. For these 12 core items, 7 screening (stem) questions were 
7 
derived from DISC-IV 
23
 and 5 questions from the Schedules for Clinical Assessment 
in Neuropsychiatry (SCAN) version 2.0 
24
, modified slightly after piloting (further 
detail available at http://www.bris.ac.uk/psychiatry/index.html (address to be 
finalised)). Clinical cross-questioning and probing was used to establish the presence 
of symptoms, and coding of all items followed the glossary definitions and rating 
rules for SCAN. Interviewers (psychologists trained in using the PLIKSi) rated 
symptoms as either not present, suspected or definitely present. Unclear responses 
after probing were always ‘rated down’, and symptoms only rated as definite when a 
credible example was provided. We included symptoms in our analyses only if they 
were not attributable to effects of sleep, fever or substance use, consistent with the 
approach of classification systems for diagnosis of functional psychotic disorders. The 
average kappa value for inter-rater reliability was 0.72 
21
. 
 
We examined two primary PLIKS outcomes: a) presence or absence of any suspected 
or definite symptoms, and b) a narrower outcome of definite symptoms only. As 
secondary analyses, we also examined whether associations were stronger for more 
frequently occurring symptoms (definite symptoms occurring monthly or more 
frequently), or for symptoms that are more characteristic of schizophrenia (any 
suspected or definite ‘bizarre’ PLIKS). These symptoms, in concordance with both 
DSM-IV and ICD-10 criteria for schizophrenia, included either third person auditory 
hallucinations or first rank delusions (delusions of control or delusions of thought 
broadcast, insertion or control). 
 
Exposures: Data on parental substance use were obtained from self-report postal 
questionnaires completed by the mother at 8, 18 and 32 weeks of pregnancy and at 2, 
8 
21, 33 and 47 months after birth of the child, and from questionnaires completed by 
the father at 18 weeks of pregnancy and at 2, 8 and 21 months after birth of the child. 
Maternal tobacco, cannabis and alcohol use were coded as the highest category of use 
during any trimester of pregnancy (tobacco: 0/1-9/10-19/>=20 cigarettes per day; 
cannabis: 0/<weekly/>=weekly use; alcohol: 0/<7/7-21/>21 units per week). For 
alcohol we also used a continuous measure of units of alcohol per week during 
pregnancy (maximum of 1
st
 and 3
rd
 trimester intake), divided by 10 to create estimates 
per 10-unit increases in alcohol intake. We also examined whether effects for each 
substance were different according to trimester of exposure. 
 
Confounders: A number of socio-demographic variables were considered as potential 
confounders: gender, parental social class (highest of both parents, based on 
occupation using the 1991 OPCS classification; coded as I-V (lowest)), maternal 
marital status during pregnancy (married, partner, single), financial difficulty during 
pregnancy, housing type (mortgaged/owned, privately rented, council), urban/rural 
index at birth (urban/town, village/hamlet), paternal smoking during pregnancy, and 
maternal and paternal education (4-levels, ranging from the lowest UK school-leaving 
qualifications up to degree level). We also considered parental age, maternal use of 
prescribed medication (analgesics or hypnotics), maternal depression during 
pregnancy (Edinburgh Postnatal Depression Scale
25
), and other family history of 
depression, schizophrenia or any mental health illness (in biological parents or 
grandparents) as potential confounders.  
 
To further examine possible confounding we compared maternal smoking during 
pregnancy with paternal smoking during pregnancy and also with maternal smoking 
9 
2-3 years post-pregnancy, before and after adjusting for confounding and for the other 
two parental smoking variables. For alcohol use we further examined possible effects 
of confounding by examining the relationship between maternal alcohol use 4-years 
post-pregnancy and PLIKS independently of effects of alcohol use during pregnancy. 
 
Variables that we considered potential mediators of the relationship between maternal 
substance use during pregnancy and risk of PLIKS in the offspring (i.e. lying on the 
causal pathway) were child WISC III total IQ score 
26
 from assessment clinic at age 8, 
and 5-minute Apgar score, gestation, and birth weight (as a marker of chronic effects 
on fetal growth), obtained from pregnancy records. 
 
Ethical approval 
Ethical approval for the study was obtained from the ALSPAC Law and Ethics 
Committee and the Local Research Ethics Committees. 
 
Statistical analysis 
Logistic regression was used to calculate odds ratios and 95% confidence intervals for 
associations between maternal substance use and PLIKS outcomes, both before and 
after adjustment for potential confounders. Our primary analyses for ordered 
categorical data (maternal tobacco and cannabis use) was to study a linear trend effect 
across increasing categories of use. In order to investigate a non-linear relationship for 
alcohol use, a quadratic term was used in addition to a linear term, and likelihood 
ratios tests (LRT) used to examine evidence of a) a non-linear relationship, and b) 
overall effect of alcohol use (linear and quadratic) on PLIKS outcomes. 
 
10 
Missing data: Children not attending the PLIKS interview were more likely to have 
mothers who smoked (35.1%) and used cannabis (3.6%) compared to those who did 
attend (19.4% & 2.6%; p<0.001 for both). However, maternal alcohol use (>1 glass 
per week) was less common in non-attendees (21.8% vs 25.2%; p<0.001). To 
examine whether missing data may have biased our results we conducted sensitivity 
analyses using multiple imputations by chained equations 
27,28
. We used the ice 
command in Stata (version 9) to impute missing data for confounders and outcomes. 
Fifty variables relating to parental socio-demographic, and child emotional, social and 
behavioural characteristics were used to impute missing data. Ten cycles of regression 
were carried out and 25 datasets imputed.
11 
RESULTS 
 
There were 734 children (11.6% of those interviewed; 95% CI 10.8%, 12.4%) who 
were rated as having suspected or definite PILKS, and 300 of these (4.7% of those 
interviewed) had definite symptoms. A summary of the potential confounders in 
relation to maternal substance use is presented in Table 1. Individually adjusting for 
sex, other family history of mental health illness and paternal age made minimal 
difference to any of the results and these were therefore omitted from the analyses. 
 
Of the children interviewed for PLIKS, there were 6332 with maternal smoking data, 
6210 with maternal cannabis use data, and 6245 with maternal alcohol data available. 
Of these, 1219 (19.3%) of mothers smoked tobacco, 4372 (70.0%) of mothers drank 
alcohol, and 157 (2.5%) of mothers took cannabis at least once during their 
pregnancy. There were 4253 adolescents with data available on PLIKS, confounders, 
and maternal use of tobacco, cannabis and alcohol, and this was the sample used for 
the main analyses. 
 
Tobacco use during pregnancy 
Maternal tobacco use during pregnancy was strongly associated with any suspected or 
definite PLIKS in the offspring (crude OR for linear trend across 4 smoking 
categories = 1.33, 95% CI 1.18, 1.49), and results were consistent with a dose-
response effect (Table 2). This was attenuated only partially after adjusting for 
confounders (adjusted OR = 1.20, 95% CI 1.05, 1.37; p = 0.007). The two 
confounders that had the greatest effect on attenuating this estimate were paternal 
smoking and single status of the mother. Further adjusting for gestation, birthweight, 
12 
5-minute Apgar score, or age 8 IQ score, as possible mediators for this association, 
had minimal effects on these results. These estimates were similar for definite PLIKS 
as an outcome although results were less precise. 
 
We further examined possible effects of confounding by studying the effects of 
paternal smoking during pregnancy and maternal smoking post-pregnancy on risk of 
PLIKS, to compare these with the effect of maternal smoking during pregnancy 
(Table 3). Paternal smoking during pregnancy was associated with any suspected or 
definite PLIKS in the crude analysis, but this was eliminated after adjusting for 
confounders and maternal smoking (adjusted OR = 1.05, 95% CI 0.95, 1.17).  
 
Maternal smoking post-pregnancy was also associated with any suspected or definite 
PLIKS in the crude analysis (Table 3), but again this was eliminated after adjusting 
for confounders and maternal smoking during pregnancy (adjusted OR = 0.95, 95% 
CI 0.79, 1.14). Maternal smoking during pregnancy and maternal smoking post-
pregnancy were quite strongly correlated (Kendall’s Tau-b = 0.76). The standard error 
for maternal smoking during pregnancy was increased by about 60% when both were 
included in the same model (Table 3), but that for maternal smoking post-pregnancy 
was relatively unchanged, indicating that collinearity is unlikely to explain the lack of 
association for smoking post-pregnancy 
29
. Note that only 3730 of the 4253 
adolescents had additional data on maternal smoking post-pregnancy and therefore 
results for maternal smoking during pregnancy in Tables 2 & 3 are slightly different 
as they are based on different datasets. 
 
13 
We examined whether the effect of maternal tobacco use differed by trimester of 
exposure. Smoking during any trimester was very strongly correlated with smoking in 
other trimesters (Kendall’s Tau-b >0.80). The offspring of mothers who used tobacco 
only in their third trimester had a greater risk of developing any suspected or definite 
PLIKS than offspring whose mothers smoked only in the first trimester (OR for 
smoking in 3
rd
 trimester only compared to 1
st
 trimester only = 2.1, 95% CI 0.96, 4.59; 
p = 0.063). There were insufficient numbers of women who only used tobacco in their 
second trimester to examine specific second trimester effects. 
 
Cannabis use during pregnancy 
Maternal cannabis use was not associated with any suspected or definite PLIKS in the 
crude analysis (OR for linear trend = 1.22, 95% CI 0.83. 1.79). The odds ratio was 
reduced after adjusting for confounders (Table 2), with adjustment for maternal 
tobacco use having the greatest impact on attenuation of this estimate (adjusted OR = 
0.94, 95% CI 0.62, 1.41; p = 0.755). Of the 157 women with PLIKS data who used 
cannabis during pregnancy, 51 (32.5%) claimed not to have smoked tobacco during 
their pregnancy. There were insufficient numbers of women using cannabis to 
examine trimester-specific effects of cannabis use. 
 
Alcohol use during pregnancy 
Although 70% of mothers drank alcohol at least once during their pregnancy the 
median number of units of alcohol per week consumed was 0 (range 0 to 102). There 
was an association between maternal alcohol intake during pregnancy and any 
suspected or definite PLIKS in the crude analysis (OR per 10 unit increase in alcohol 
= 1.24, 95% CI 1.03, 1.50), and this was not substantially altered after adjustment 
14 
(adjusted OR per 10 units = 1.19, 95% CI 0.97, 1.45). This was a non-linear effect 
(likelihood ratio for inclusion of quadratic term in crude model χ2 = 7.5, df (1), p = 
0.006). Likelihood ratio test results for the overall effect of alcohol on risk of PLIKS 
are presented in Table 2. Further adjusting for possible mediators of this association 
had minimal effects on these results. 
The increase in risk of suspected or definite PLIKS was primarily present in the 
offspring of the 25 mothers (0.6% of the sample) who drank >21 units per week. 
When omitting this extreme group, as a sensitivity analysis, there was no evidence of 
a non-linear relationship (χ2 = 0.3, df (1), p = 0.566) and no evidence of association 
between alcohol use and PLIKS (adjusted OR per 10 units = 0.97, 95% CI 0.72, 1.31) 
(Table 2). 
 
We also examined trimester-specific effects of maternal alcohol use. Alcohol intake 
during the 1
st
 and 3
rd
 trimesters were correlated, though insufficiently to render 
collinearity a problem in an analysis with both included in the same model (Pearson 
co-efficient = 0.54). Within such a model, 1
st
 trimester alcohol use (adjusted OR per 
10 units = 1.41, 95% CI 0.95, 2.09) but not 3
rd
 trimester use (adjusted OR per 10 units 
= 0.99, 95% CI 0.63, 1.55) was associated with increased risk of PLIKS, although the 
confidence intervals overlapped substantially. 
 
We further examined possible effects of confounding by studying the effects of 
maternal alcohol use 4 years post-pregnancy on risk of PLIKS in the offspring. The 
correlation between alcohol use during and post-pregnancy was not very strong 
(Pearson co-efficient = 0.29). There was no evidence of any association between 
maternal alcohol use post-pregnancy and any suspected or definite PLIKS either 
15 
before or after adjusting for alcohol use during pregnancy (LRT for both linear and 
quadratic terms, χ2 = 4.0, df (2), p = 0.139). 
 
Secondary analyses: Frequency of PLIKS & ‘bizarre’ PLIKS 
There were 165 children (2.6% of those interviewed) with definite, frequent 
(occurring ≥monthly) PLIKS, and 233 (3.6%) with suspected or definite ‘bizarre’ 
PILKS. There was no consistent pattern that associations were stronger for either of 
these outcomes. 
 
Missing data 
Results from the multivariable multiple-imputation models were very similar to those 
using the main dataset, although more precisely estimated, whether we imputed 
confounders only or outcome measures too.
16 
DISCUSSION 
 
Maternal smoking during pregnancy was associated with an increased risk of 
psychotic symptoms in the children, with evidence of a dose-response effect whereby 
risk of PLIKS was highest in the offspring of mothers who smoked most heavily. This 
association was not mediated by childhood IQ or by markers of pre- or peri-natal 
adversity. Maternal alcohol use was also associated with PLIKS, although this effect 
was present almost exclusively in the offspring of women drinking more than 21 units 
of alcohol per week in early pregnancy. Maternal cannabis use was uncommon, 
reducing the power to detect any association with this exposure. Although use of 
cannabis was also more common in offspring with PLIKS, this association was 
eliminated after adjusting for confounders, and particularly by maternal tobacco use. 
 
Confounding 
Maternal smoking was strongly associated with markers of adverse socio-
demographic characteristics in our data, similar to previous reports 
30
, and similar to 
psychosis 
31
. The socio-demographic characteristics of alcohol use in pregnancy were 
quite different to those of smoking, also similar to previous reports 
32
. The association 
between maternal smoking and PLIKS was attenuated by about 40% after adjusting 
for a broad range of confounders. However conventional epidemiological methods for 
dealing with confounding may be particularly problematic when assessing intrauterine 
influences on offspring health outcomes 
13
. One approach to overcome this is to 
compare the effects of maternal exposure during pregnancy with those of paternal 
exposure, as the latter is likely to reflect, to some extent, similar confounding 
characteristics to the former 
13
. Maternal exposure during pregnancy can also be 
17 
compared with maternal exposure post-pregnancy, although such a comparison is 
more problematic, and especially for smoking, given that women who continue to 
smoke throughout pregnancy may differ substantially from those who abstain during 
this period. 
 
Estimates of association for paternal smoking and maternal smoking post-pregnancy 
were smaller than for smoking during pregnancy, and both were substantially 
attenuated after adjusting for maternal smoking during pregnancy. This lends some 
support for a biological effect of tobacco exposure in-utero on risk of psychotic 
symptoms, although as the confidence intervals for paternal smoking overlap slightly 
with those for maternal smoking during pregnancy we cannot conclude that these 
exposures are clearly different from each other. 
 
For alcohol use, adjustment for confounding had minimal effect on results, and there 
was no association between alcohol use in the post-pregnancy period and PLIKS 
independent from effects of use during pregnancy. However, the results of the 
sensitivity analyses indicate there was minimal association between alcohol use and 
PLIKS once women drinking more than 21 units of alcohol per week were excluded 
from the analysis. This level of drinking occurred in less than 1% of women in this 
cohort. Such women are likely to be very different from other women in the cohort in 
relation, for example, to personality traits and mental health characteristics. Despite 
the minimal effect of adjusting for confounders, it is difficult to be confident that this 
pattern of association is not due to confounding. 
 
 
18 
Bias 
Although this is a large cohort, with a wealth of detailed information, missing data 
due to attrition and wave non-response in this cohort was not in-substantial, a problem 
common to other large-scale longitudinal studies 
33,34
. All estimates however were 
similar in the multiple-imputation analyses, indicating that attrition was unlikely to 
have substantially biased the results. 
 
Some under-reporting of substance use is likely to have occurred, and perhaps 
especially for cannabis use as this is illegal in the UK. Furthermore, a measure of 
weekly consumption of alcohol may not adequately capture peak levels of fetal 
exposure due to binge drinking patterns. Such misclassification tends to lead to under-
estimation of effects, though only if this were non-differential with respect to 
outcome. 
 
Possible biological mechanisms 
Animal studies indicate that fetal nicotine exposure can result in long-term structural 
and functional changes 
7
, including decreased neuronal density and size in the 
hippocampus and cortex, altered regulation of neuronal apoptosis 
7,15
, and increased 
expression of receptors for acetylcholine, which plays a critical role in brain 
maturation through modulation of axonogenesis and synaptogenesis 
15
. However, 
difficulties exist, both conceptually and pragmatically, in the interpretation of results 
from animal models in relation to effects in humans. 
 
We are not aware of animal studies to date that have examined the effects of nicotine 
exposure in-utero on putative endophenotypes of schizophrenia. Although 
19 
endophenotypes of schizophrenia that can be modelled in animals are yet to be clearly 
determined this could potentially become an informative area for future research. 
 
We observed suggestive evidence that maternal smoking during the third trimester 
was most strongly associated with risk of PLIKS, although results from sub-group 
comparisons should be interpreted cautiously. This is rather inconsistent with results 
from studies of famine 
35,36
 and influenza 
37,38
, where early pregnancy exposure is 
associated with greatest risk of schizophrenia, but may reflect different sensitive 
periods of risks in brain development for different types of exposure. Maternal 
smoking 
5,39
, particularly during late pregnancy 
40
 is thought to lead to lower birth 
weight 
7
. However, adjusting for birthweight, as well as for gestation and 5-minute 
Apgar score had no effect on the results, and although these measures are likely to be 
rather crude markers of pre- and peri-natal adversity, it seems unlikely that such 
adversity mediates or confounds the relationship between maternal smoking and 
offspring psychotic experiences. 
 
Alcohol use is associated with adverse effects on placental development and function 
41
, and adverse perinatal outcomes, although evidence of adverse effects is not strong 
for low to moderate levels of alcohol consumption during pregnancy 
42
. Adverse long-
term neuro-behavioural and cognitive consequences of alcohol use have also been 
described, albeit more inconsistently than for tobacco use, in both human and animal 
studies 
4
. 
 
It is quite likely that biological effects of any exposures in-utero will impact indirectly 
upon risk of psychotic phenomena, for example through effects on impulsivity, 
20 
attention, or subtle effects on cognition (that may not be picked up through global 
cognitive measures such as IQ), and which can potentially also affect development of 
other, non-psychotic, psychopathology. In the EDSP study, maternal smoking was not 
associated specifically with psychotic symptoms, but also with any diagnosis of 
psychiatric disorder 
20
. Future studies that aim to increase knowledge about such 
pathways will help our understanding of the mechanisms underlying disease 
pathogenesis.  
 
Although at present the status of non-clinical psychosis-like experiences in relation to 
rare clinical disorders such as schizophrenia is not clear, results from two cohort 
studies 
43,44
 indicate that the presence of such symptoms may lead to increased risk of 
clinically important psychotic disorders in later life.  Furthermore, as such symptoms 
are not uncommon in population-based studies 
43,45-48
, and are associated with 
decreased occupational and social functioning over time 
44,49
, these phenomena may 
have a large impact on population health and quality of life outside the arena of 
clinical services, in the same way as depression does. This further highlights the 
importance of understanding the mechanisms underlying the aetiology of non-clinical 
psychosis-like symptoms.  
 
In our cohort, approximately 19% of adolescents attending the PLIKS interview had 
mothers who smoked during pregnancy. If our results for the association between 
maternal smoking and PLIKS are non-biased and truly reflect a causal relationship, 
we can estimate that about 20% of adolescents in this cohort would not have 
developed psychotic symptoms if their mothers had not smoked (the population 
attributable fraction). Therefore, although the effect size of association for maternal 
21 
smoking is rather modest, the frequency of this exposure means that maternal 
smoking may nevertheless be an important risk factor for the development of 
psychotic experiences in the population. 
 
Conclusion 
Observational studies are limited in determining causality due to potential problems of 
residual confounding. We observed an association between maternal, but not paternal, 
smoking during pregnancy and risk of psychotic symptoms in the offspring, consistent 
with accumulating evidence from animal models of adverse effects on brain 
development from in-utero nicotine exposure. These findings suggest that risk factors 
for development of non-clinical psychotic experiences may operate during early 
development. Future studies of how in-utero exposure to tobacco affects cerebral 
development and function may lead to increased understanding of the pathogenesis of 
psychotic phenomena. 
22 
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Table 1: Descriptive summary of confounders (number & percent of cohort) in relation to maternal substance use during pregnancy 
 
 Low social 
class 
Income 
support 
Council 
housing 
Single 
status 
(mother) 
Rural   
birth 
Low 
maternal 
education 
Low 
paternal 
education 
Mother’s 
age >30 
Medication 
in 
pregnancy 
Maternal 
depression 
(EPDS≥15) 
Paternal 
tobacco use 
Tobacco use            
Non-smokers 3462 (39.9) 561 (6.3) 7787 (81.6) 749 (7.7) 623 (6.3) 1408 (15.3) 1328 (17.9) 3371 (33.7) 5882 (62.2) 453 (4.8) 1890 (23.6) 
Smokers 1722 (60.2) 585 (18.9) 1815 (51.2) 734 (19.8) 139 (3.7) 1101 (13.9) 808 (33.9) 803 (20.9) 2557 (73.1) 413 (11.6) 1829 (68.6) 
Cannabis use            
None 4849 (44.3) 1000 (8.8) 9153 (75.3) 1296 (10.4) 723 (5.8) 2255 (19.3) 1967 (21.1) 3913 (30.8) 7894 (64.7) 740 (6.1) 3348 (33.9) 
≥1 once 162 (53.8) 102 (30.3) 152 (39.7) 105 (26.8) 8 (2.0) 84 (24.0) 76 (29.7) 87 (21.4) 272 (71.0) 64 (16.9) 214 (73.8) 
Alcohol use            
<1 glass/wk 4052 (47.2) 864 (9.6) 7098 (73.2) 1058 (10.6) 535 (5.3) 1931 (20.9) 1713 (23.1) 2756 (27.0) 6164 (63.6) 627 (6.4) 2809 (34.6) 
≥1 glass/wk 1000 (36.7) 254 (9.1) 2279 (76.3) 376 (12.3) 212 (6.9) 490 (16.8) 381 (16.9) 1308 (42.3) 2093 (69.4) 199 (6.6) 852 (35.1) 
 
For tobacco use, all p<0.001; for cannabis use, all p<0.05; for alcohol use, all p<0.01 except income support (p=0.43),  paternal smoking (p=0.63) & maternal depression 
(p=0.70). Note that confounding variables dichotomised only for the purpose of this table and not for analyses; data in table is on whole cohort and not just those with PLIKS 
data. EPDS = Edinburgh post-natal depression scale
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Table 2: Crude and adjusted
a
 odds ratios & 95% CI for PLIKS by maternal substance 
use during pregnancy 
 
a
Adjusted for other substances used, and all variables in table 1; dataset with no missing data for 
confounders = 4253; 
b 
Results for linear and quadratic terms for alcohol use are with both included in 
same model 
 
 N Suspected or 
definite PLIKS 
Suspected or 
definite PLIKS 
Definite PLIKS Definite PLIKS 
  Crude Adjusted Crude Adjusted 
Tobacco      
 None 3579 1.0 1.0 1.0 1.0 
 1-9 cigarettes/day 295 1.15 (0.79, 1.66) 0.92 (0.63, 1.36) 1.53 (0.92, 2.53) 1.25 (0.73, 2.14) 
 10-19 cigarettes/day 266 1.88 (1.35, 2.61) 1.47 (1.02, 2.12) 2.33 (1.48, 3.66) 1.65 (0.99, 2.75) 
≥20 cigarettes/day 113 2.30 (1.45, 3.65) 1.84 (1.12, 3.03) 2.03 (1.01, 4.10) 1.54 (0.73, 3.25) 
Linear trend 4253 1.33 (1.18, 1.49)  
p <0.001 
1.20 (1.05, 1.37)    
p = 0.007 
1.39 (1.18, 1.63) 
p <0.001 
1.21 (1.010 1.47) 
p = 0.047 
Cannabis      
None 4175 1.0 1.0 1.0 1.0 
<1/week 37 0.95 (0.34, 2.70) 0.58 (0.20, 1.70) 0.57 (0.08, 4.20) 0.34 (0.04, 2.56) 
≥1/week 41 1.62 (0.71, 3.66) 1.04 (0.45, 2.43) 1.63 (0.50, 5.32) 1.12 (0.33, 3.84) 
Linear trend 4253 1.22 (0.83, 1.79)  
p = 0.317 
0.94 (0.62, 1.41)    
p = 0.755 
1.16 (0.65, 2.09) 
p = 0.616 
0.91 (0.49, 1.71) 
p = 0.776 
Alcohol      
None 2522 1.0 1.0 1.0 1.0 
<7 units/week 1293 0.92 (0.74, 1.14) 0.92 (0.74, 1.15) 0.67 (0.48, 0.94) 0.68 (0.48, 0.96) 
7-21 units/week 410 1.05 (0.77, 1.48) 1.00 (0.71, 1.39) 0.58 (0.33, 1.04) 0.56 (0.31, 1.02) 
>21 units/week 28 2.58 (1.09, 6.11) 2.40 (0.99, 5.83) 2.14 (0.64, 7.17) 1.86 (0.54, 6.42) 
Linear (per 10 units)
b 
4253 0.80 (0.51, 1.25) 0.75 (0.47, 1.19) 0.77 (0.48, 1.25) 0.73 (0.45, 1.18) 
Quadratic (linear
2
)
b 
4253 1.21 (1.00, 1.47) 1.22 (1.00, 1.49) 1.04 (0.97, 1.12) 1.04 (0.97, 1.12) 
Likelihood ratio (for 
overall alcohol)
b 
4253 χ2 = 9.8, df (2),     
p = 0.008 
χ2 = 8.3, df (2),      
p = 0.016 
χ2 = 1.3, df (2),      
p = 0.522 
χ2 = 1.8, df (2),      
p = 0.415 
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Table 3: Crude and adjusted odds ratios & 95% CI for any suspected or definite 
PLIKS in relation to parental tobacco use within and outside the pregnancy period 
(linear trend across 4 smoking categories) 
 
 
 
 OR (95% CI) for suspected or definite PLIKS 
 N 
exposed 
Crude Adjusted    
(model 1)
a 
Adjusted    
(model 2)
b 
p-value 
Maternal smoking vs. non-
smoking during pregnancy
 
634 1.32 (1.17, 1.49) 1.23 (1.08, 1.39) 1.22 (0.99, 1.49) 0.059 
Paternal smoking vs. non-
smoking during pregnancy
 
1051 1.15 (1.05, 1.26) 1.10 (1.00, 1.21) 1.05 (0.95, 1.17) 0.336 
Maternal smoking vs. non-
smoking post-pregnancy 
759 1.22 (1.10, 1.36) 1.10 (0.97, 1.24) 0.95 (0.79, 1.14) 0.563 
 
a
Adjusted for other alcohol use, cannabis use, and variables in table 1; 
b
Additionally adjusted for other 
variables in table 3; N with no missing data for any of these variables = 3730 
 
 
 
 
 
 
 
 
